| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Revenue | $88.4M | -4.7% |
| Cost of Revenue | $26.4M | -4.2% |
| Gross Profit | $62.0M | -4.9% |
| R&D Expense | $29.6M | +11.2% |
| SG&A Expense | $8.6M | -17.9% |
| Operating Income | $4.4M | -25.8% |
| Pre-tax Income | $5.6M | -42.0% |
| Income Tax | -$26.6M | -1473.4% |
| Net Income | $32.3M |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $62.9M | -10.1% |
| Accounts Receivable | $32.8M | +3.3% |
| Current Assets | $100.6M | -6.1% |
| Total Assets | $148.0M | +15.8% |
| Current Liabilities | $62.2M | -0.7% |
| Total Liabilities | $67.3M | -3.0% |
| Stockholders' Equity | $80.7M | +38.0% |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $5.3M | -57.7% |
| Capital Expenditures | $565K | +185.4% |
| Investing Cash Flow | -$565K | -185.4% |
| Financing Cash Flow | -$14.4M | +6.5% |
| Free Cash Flow | $4.7M | -61.7% |
| +314.6% |
| EPS (Basic) | $1.15 | +360.0% |
| EPS (Diluted) | $1.13 | +352.0% |